1 – 6 of 6
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice : one-yearresults of the ACURATE neo2 PMCF Study
2024) In EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20(1). p.85-94(
- Contribution to journal › Article
- 2022
-
Mark
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR : A Secondary Analysis of the REPRISE III Randomized Clinical Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis : The REPRISE III Randomized Clinical Trial
(
- Contribution to journal › Article
- 2017
-
Mark
Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort)
(
- Contribution to journal › Article
-
Mark
Repositionable percutaneous aortic valve implantation with the LOTUS valve : 30-day and 1-year outcomes in 250 highrisk surgical patients
(
- Contribution to journal › Article
-
Mark
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients : Results from the REPRISE II trial with extended cohort
(
- Contribution to journal › Article